104 related articles for article (PubMed ID: 7321143)
1. Augmented malondialdehyde production by platelets from patients with cerebrovascular disorders.
Satoh K; Takamatsu S; Sakuta S; Mizuno S; Metoki H; Takamatsu M
Jpn Circ J; 1981 Dec; 45(12):1335-41. PubMed ID: 7321143
[TBL] [Abstract][Full Text] [Related]
2. An improved malondialdehyde assay for estimation of thromboxane synthase activity in washed human blood platelets.
Panse M; Block HU; Förster W; Mest HJ
Prostaglandins; 1985 Dec; 30(6):1031-40. PubMed ID: 3937179
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
Aviram M; Sirtori CR; Colli S; Maderna P; Morazzoni G; Tremoli E
Biochem Med; 1985 Aug; 34(1):29-36. PubMed ID: 4052061
[TBL] [Abstract][Full Text] [Related]
4. [Observations on levels of TXA2 and PGI2 and the generation of platelet MDA in patients with chronic cor pulmonale].
Zhou YC
Zhonghua Jie He He Hu Xi Za Zhi; 1987 Apr; 10(2):80-2, 123-4. PubMed ID: 3319212
[No Abstract] [Full Text] [Related]
5. Low platelet arachidonic acid in young patients with brain infarction.
Färkkilä MA; Rasi V; Tilvis RS; Ikkala E; Viinikka L; Ylikorkala O; Färkkilä AM; Miettinen TA
Thromb Res; 1987 Dec; 48(6):721-7. PubMed ID: 2829382
[TBL] [Abstract][Full Text] [Related]
6. Platelet malondialdehyde and plasma thromboxane B2 formation in patients with obliterative arteriosclerosis of the lower limbs.
Bodzenta A; Bielawiec M; Krupiński K; Wojtukiewicz M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):804-7. PubMed ID: 6188668
[TBL] [Abstract][Full Text] [Related]
7. [Relation between malondialdehyde generation by platelets and plasma thromboxane B2 and diagnostic classification by syndrome differentiation of traditional Chinese medicine in stroke during acute stage].
Lin ZX; Dong W; Li PC
Zhong Xi Yi Jie He Za Zhi; 1991 Dec; 11(12):714-6, 707. PubMed ID: 1821334
[TBL] [Abstract][Full Text] [Related]
8. [MDA formation by platelets and plasmatic BTG levels in patients suffering from acute myocardial infarction (author's transl)].
Davì G; Traina M; Novo S; Pinto A; Piraino GL; Marano G; Alfano R
G Ital Cardiol; 1981; 11(9):1238-41. PubMed ID: 6173283
[TBL] [Abstract][Full Text] [Related]
9. Effects of vinblastine on malondialdehyde formation, serotonin release and aggregation in human platelets.
Brammer JP; Kerecsen L; Maguire MH
Eur J Pharmacol; 1982 Jul; 81(4):577-85. PubMed ID: 6811295
[TBL] [Abstract][Full Text] [Related]
10. Response of thromboxane B2, malondialdehyde and platelet sensitivity to 3 weeks low-dose aspirin (ASA) in healthy volunteers.
Sinzinger H; Virgolini I; Peskar BA
Thromb Res; 1989 Feb; 53(3):261-9. PubMed ID: 2497545
[TBL] [Abstract][Full Text] [Related]
11. Malondialdehyde formation by blood platelets: a diagnostic test to assess acetylsalicylic acid induced thrombocytopathy?
Hovinga JK; Felix R; Furlan M; Lämmle B
Thromb Res; 1990 Jul; 59(1):89-95. PubMed ID: 2399531
[TBL] [Abstract][Full Text] [Related]
12. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
Busse WD; Seuter F
Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
[TBL] [Abstract][Full Text] [Related]
13. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.
Rajtar G; Livio M; Merino J; de Gaetano G
Thromb Haemost; 1980 Oct; 44(2):49-51. PubMed ID: 7455990
[TBL] [Abstract][Full Text] [Related]
14. Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets.
Pönicke K; Förster W
Biomed Biochim Acta; 1984; 43(8-9):S459-62. PubMed ID: 6440558
[TBL] [Abstract][Full Text] [Related]
15. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Maguire MH; Csonka-Khalifah L
Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
[TBL] [Abstract][Full Text] [Related]
16. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Ostermann G; Block HU; Till U
Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
[TBL] [Abstract][Full Text] [Related]
17. [Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid].
Sinzinger H; Gisslinger H; Linkesch W; Ludwig H; Flener R; Peskar BA
Wien Klin Wochenschr; 1988 Nov; 100(21):715-8. PubMed ID: 3149432
[TBL] [Abstract][Full Text] [Related]
18. Pressure-induced metabolic activation of platelets demonstrated in vitro by determination of malondialdehyde formation.
Torsellini A; Doni L; Palinski W; Guidi G; Lombardi V
Thromb Haemost; 1984 Aug; 52(1):4-6. PubMed ID: 6238444
[TBL] [Abstract][Full Text] [Related]
19. [Changes in platelet production of malondialdehyde in diabetics treated with dilazep].
Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1838-41. PubMed ID: 6671043
[TBL] [Abstract][Full Text] [Related]
20. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
